Table 4.
Indicator | Switzerland 2005–2006 | United States* 2006 | |
---|---|---|---|
Smoking cessation counseling | |||
7 | Annual advice to quit | 71.7 | 73.8 |
8 | Pharmacotherapy offered to smokers | 48.1 | 43.9 |
Diabetes | |||
16 | HbA1c screening† | 71.9 | 87.5 |
17 | Annual eye exam screening | 55.8 | 54.7 |
18 | LDL-cholesterol screening | 97.6 | 83.4 |
19 | Monitoring nephropathy‡ | 65.1 | 79.7 |
Cardiovascular disease | |||
35 | Beta blockers a year after heart attack | 81.7 | 72.5 |
Cancer screening | |||
11 | Colorectal cancer | 35.2 | 54.5 |
12 | Breast cancer§ | 39.7 | 72.0 |
Influenza immunization | |||
13 | All patients >65 years‖ | 35.2 | 70.3 |
14 | Potentially immunocompromised <65 years | 29.3 | 45.6 |
*Selection of similar indicators on 2006 data from HEDIS,12 when available
†HbA1c screening twice a year in Switzerland, but once a year in the US
‡Recommended screening for proteinuria in Switzerland, medical attention for kidney disease in the US
§HEDIS US 2005 rates were reported here as recommended screening age (50–70 years) was the same as in Switzerland, instead of 40–70 years (since 2006 in the US)
‖HEDIS US 2005 rates were reported here because such Medicare data were not available in 2006